Abbott Labs (ABT) PT Raised to $132 at Barclays
Get Alerts ABT Hot Sheet
Price: $111.11 +0.18%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Abbott Labs (NYSE: ABT) to $132.00 (from $127.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
- Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share